Last reviewed · How we verify
NCT06689683
Fluoroscopy Activation Interval in SWL
NA trial testing Shock wave lithotripsy in Kidney Calculi in 158 participants. Completed in 5 January 2024.
5 January 2024
Quick facts
| Lead sponsor | Lütfi Kırdar City Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 158 |
| Start date | 27 July 2020 |
| Primary completion | 5 January 2024 |
| Estimated completion | 5 January 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Shock wave lithotripsy
Conditions studied
- Kidney Calculi — all drugs for Kidney Calculi →
Sponsor
Lütfi Kırdar City Hospital
Who can join
Adults 18 to 75, any sex, with Kidney Calculi. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Shock wave lithotripsy (SWL) is a noninvasive method widely used as the first step in treating stone disease. This study aimed to reduce radiation exposure to patients and practitioners during SWL sessions by extending the intervals of fluoroscopy controls. The main questions it aims to answer are: * Will radiation exposure be reduced? * Will the stone-free status be affected? The researchers will compare the fluoroscopic control intervals of 250 shocks and 500 shocks. Participants will: * Take to a maximum of 3 sessions. * Check once a week * Group 1 was fluoroscopically monitored every 250 shocks, and Group 2 was fluoroscopically monitored every 500 shocks
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparison of 2 different fluoroscopy activation intervals in shock wave lithotripsy: a prospective randomized study.
Çanakcı C, Şahan A, Özkaptan O, Dinçer E, et al · · 2025 · PMID 40785738 · DOI 10.20452/wiitm.2025.17947
Verify or expand the search:
- PubMed search for NCT06689683
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Kidney Calculi
Currently open trials in the same condition.
- NCT06989320 — Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease · NA · recruiting
- NCT06667557 — Comparing Super Pulse Fiber Thulium Laser and Holmium Laser for Ureteral Stone Fragmentation During Ureteroscopy · recruiting
- NCT07238803 — Outcomes of Using FANS With FURS in TTT of Lower Calyceal Stones. · NA · recruiting
- NCT06684756 — Comparison of Vacuum-Assisted and Conventional Ureteral Access Sheath in Retrograde Intrarenal Surgery · NA · active not recruiting
- NCT06331546 — Gut Oxalate Absorption in Calcium Oxalate Stone Disease · NA · recruiting
Other Lütfi Kırdar City Hospital trials
Trials by the same sponsor.
- NCT07325656 — Comparison of Scoring Systems in Gastrointestinal Cancer Surgery · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06689683 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lütfi Kırdar City Hospital
- Last refreshed: 14 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06689683.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing